Factor VII Activity (1:5 dilution)

This test measures the activity of Factor VII, a clotting protein that helps start the clotting process when a blood vessel is injured. The result reflects how well your Factor VII works compared to normal clotting function. Laboratories perform the assay at a defined dilution to keep the measurement in an accurate range and to detect both decreases and increases in activity.

Factor VII is produced in the liver and depends on vitamin K. If Factor VII is too low or not working properly, you may bruise or bleed more easily. If it is higher than expected, it can be associated with a tendency to form clots in some situations.

Your clinician may order this test if you have unexplained bleeding, a prolonged prothrombin time, suspected inherited Factor VII deficiency, or conditions that affect vitamin K or the liver. It is also used to monitor the effects of vitamin K antagonists and to explore the cause of abnormal screening coagulation tests.

Understanding your Factor VII activity helps guide decisions about treatment, such as vitamin K replacement, adjusting anticoagulant medications, or further evaluation for liver or nutritional problems. In rare cases, it can help confirm a hereditary deficiency when bleeding symptoms or family history suggest it.

A lower-than-expected activity can occur with inherited Factor VII deficiency, use of vitamin K antagonists, vitamin K deficiency from poor intake or malabsorption, severe liver disease, or widespread clotting activation. Certain antibiotics and other medicines can also reduce vitamin K–dependent clotting proteins. Your clinician will interpret the result alongside other tests, medications, diet, and medical history.

A higher-than-expected activity can be seen with acute inflammation, hormonal influences, or genetic variation. If your result is unexpected, your care team may repeat the test to rule out specimen issues, review medications and supplements, check related tests such as prothrombin time and liver function, or order specialized studies to confirm the cause. Most findings can be addressed with targeted steps, and urgent treatment is rarely needed unless you have active bleeding or clotting.